Thiel Johannes Tobias, Bauer Michael, Daigeler Adrien, Kavaka Vladyslav, Kolbenschlag Jonas, Steiner Dominik, Storz Anna, Hoffmann Sebastian
Department of Hand, Plastic, Reconstructive and Burn Surgery, BG Trauma Center Tübingen, University of Tübingen, Schnarrenbergstrasse 95, Tübingen 72076, Germany.
Department of Hand, Plastic, Reconstructive and Burn Surgery, BG Trauma Center Tübingen, University of Tübingen, Tübingen, Germany.
Ther Adv Med Oncol. 2025 Feb 18;17:17588359251317842. doi: 10.1177/17588359251317842. eCollection 2025.
Radiation-associated angiosarcoma of the breast (RAASB) is a rare secondary angiosarcoma that typically develops subsequent to breast-conserving therapy for breast cancer. The parameters of the resection width and depth remain the subject of considerable controversy. More recent data indicate that radical resection of the complete radiation field at the thorax is associated with improved local control and survival.
The present study investigates the radical resection technique of the entire radiation field and subsequent defect coverage in RAASB, as well as the medium-term follow-up.
Monocentric, retrospective, and non-comparative study.
From January 2017 to January 2024 a total of 10 patients with RAASB were treated at our hospital. The radical resection technique was employed in the treatment of all patients, encompassing the entire radiation field. Three patients received local flaps (two of whom received vertical and transversal rectus abdominis muscle flaps and one received a local random pattern flap), while the remaining seven were treated with split-thickness skin grafts for defect coverage.
The median age at initial diagnosis of breast cancer was 59.3 ± 9.41 years, while that of RAASB was 66.2 ± 8.32 years. The median latency period between the start of irradiation of the chest wall and the initial presentation of RAASB was 6.5 ± 3.08 years. The cumulative median total radiation dose was 57.23 ± 8.34 Gray (cumulative Gray) in 9 of the 10 patients. The overall survival (OS) was 80% in the cohort, with a median follow-up period of 40.0 ± 27.96 months. Three patients exhibited local relapses following radical resection, with two of these patients ultimately succumbing to their condition.
Patients with RAASB may benefit from a radical resection of the entire radiation field. Despite the relatively mutilating nature of the procedure, the radical resection technique may have the potential to reduce the rate of local recurrence and prolong OS.
乳腺放疗相关血管肉瘤(RAASB)是一种罕见的继发性血管肉瘤,通常在乳腺癌保乳治疗后发生。手术切除宽度和深度的参数仍存在很大争议。最新数据表明,对胸部完整放疗区域进行根治性切除与改善局部控制和生存率相关。
本研究探讨RAASB中整个放疗区域的根治性切除技术及后续缺损覆盖情况,以及中期随访结果。
单中心、回顾性、非对照研究。
2017年1月至2024年1月,我院共治疗10例RAASB患者。所有患者均采用根治性切除技术,切除范围包括整个放疗区域。3例患者接受局部皮瓣(其中2例接受腹直肌垂直和横行皮瓣,1例接受局部随意皮瓣),其余7例采用中厚皮片移植覆盖缺损。
乳腺癌初诊时的中位年龄为59.3±9.41岁,RAASB初诊时的中位年龄为66.2±8.32岁。胸壁开始放疗至RAASB初次出现的中位潜伏期为6.5±3.08年。10例患者中有9例的累积中位总辐射剂量为57.23±8.34格雷(累积格雷)。该队列的总生存率(OS)为80%,中位随访期为40.0±27.96个月。3例患者在根治性切除后出现局部复发,其中2例最终死亡。
RAASB患者可能从整个放疗区域的根治性切除中获益。尽管该手术相对具有致残性,但根治性切除技术可能有降低局部复发率和延长总生存期的潜力。